User:Mr. Ibrahem/Fremanezumab

Fremanezumab, sold under the brand name Ajovy, is a medication used to prevent migraines. It not a preferred option due to the cost. It is given by injection under the skin.

Common side effect include pain and redness at the site of injection. Other side effects may include allergic reactions. Safety in pregnancy and breastfeeding is unclear. It is in the calcitonin gene-related peptide (CGRP) antagonist class of medications.

Fremanezumab was approved for medical use in the United States in 2018, Europe in 2019, and the UK in 2020. In the United States it costs 625 USD per month as of 2021. In the United Kingdom this amount costs the NHS about £450.